ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

NRBO NeuroBo Pharmaceuticals Inc

3.73
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:00:02
15분 지연
기업명 주식 심볼 시장 주식 타입
NeuroBo Pharmaceuticals Inc NRBO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 3.73 20:00:02
개장가 저가 고가 종가 전일 종가
3.73
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202421:01PRNUSNeuroBo to Present Latest Pre-Clinical Data on..
17/04/202421:05PRNUSNeuroBo Pharmaceuticals Doses First Patient in Its Phase 1..
01/04/202421:01PRNUSNeuroBo Pharmaceuticals Completes Enrollment of Part 1 of..
28/03/202421:01PRNUSNeuroBo Pharmaceuticals Reports Year End 2023 Financial..
13/03/202421:01PRNUSNeuroBo Pharmaceuticals Receives Safety Review Committee..
04/03/202422:01PRNUSNeuroBo Pharmaceuticals Appoints Seasoned Life Science..
04/03/202421:30EDGAR2Form 8-K - Current report
29/02/202422:30EDGAR2Form 8-K - Current report
29/02/202422:01PRNUSNeuroBo Pharmaceuticals Receives First Site IRB Approval for..
14/02/202422:52EDGAR2Form 8-K - Current report
12/02/202422:01PRNUSNeuroBo Pharmaceuticals to Participate in the BIO CEO &..
01/02/202422:30EDGAR2Form 8-K - Current report
01/02/202422:01PRNUSNeuroBo Pharmaceuticals Announces FDA Clearance of IND for a..
18/01/202422:30EDGAR2Form 8-K - Current report
18/01/202422:01PRNUSNeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety..
09/01/202422:45EDGAR2Form 8-K - Current report
09/01/202422:30PRNUSNeuroBo Pharmaceuticals Regains Compliance with Nasdaq..
02/01/202422:01PRNUSNeuroBo to Participate in Industry and Investor Conferences..
28/12/202323:00EDGAR2Form 8-K - Current report
28/12/202322:45PRNUSNeuroBo Pharmaceuticals Submits IND Application to the FDA..
19/12/202323:03EDGAR2Form 8-K - Current report
19/12/202322:43PRNUSNeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock..
07/12/202323:20EDGAR2Form 8-K - Current report
01/12/202322:31PRNUSNeuroBo to Participate in Investor Conferences in December
14/11/202306:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:14EDGAR2Form 8-K - Current report
14/11/202306:05PRNUSNeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial..
06/11/202322:20EDGAR2Form 8-K - Current report
06/11/202322:05PRNUSNeuroBo Pharmaceuticals Strengthens Board of Directors with..
30/10/202321:06EDGAR2Form 8-K - Current report
17/10/202321:01PRNUSNeuroBo to Present at the H.C. Wainwright 7th Annual NASH..
22/09/202321:03EDGAR2Form 8-K - Current report
20/09/202305:15EDGAR2Form 8-K - Current report
15/09/202321:11EDGAR2Form 8-K - Current report
15/09/202321:01PRNUSNeuroBo Pharmaceuticals Doses First Patient in Its Phase 2a..
25/08/202305:15EDGAR2Form 8-K - Current report
15/08/202305:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/08/202321:18EDGAR2Form 8-K - Current report
14/08/202321:01PRNUSNEUROBO PHARMACEUTICALS APPOINTS HYUNG HEON KIM AS CHIEF..
10/08/202305:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202305:20EDGAR2Form 8-K - Current report
10/08/202305:05PRNUSNeuroBo Pharmaceuticals Reports Second Quarter 2023..
09/08/202305:15EDGAR2Form 8-K - Current report
03/08/202321:15EDGAR2Form 8-K - Current report
03/08/202321:01PRNUSNeuroBo Pharmaceuticals Receives First Site IRB Approval for..
02/08/202321:01PRNUSNeuroBo Pharmaceuticals Enters Into Term Sheet With MThera..
28/07/202319:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/07/202319:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/07/202319:02EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
29/06/202321:36EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock